Bvf Inc Olema Pharmaceuticals, Inc. Transaction History
Bvf Inc
- $2.54 Billion
- Q2 2025
A detailed history of Bvf Inc transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Bvf Inc holds 5,295,893 shares of OLMA stock, worth $56.5 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
5,295,893
Previous 5,295,893
-0.0%
Holding current value
$56.5 Million
Previous $19.9 Million
13.3%
% of portfolio
0.89%
Previous 0.88%
Shares
6 transactions
Others Institutions Holding OLMA
# of Institutions
126Shares Held
68.8MCall Options Held
0Put Options Held
31.4K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$73 Million8.75% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.76MShares$72.1 Million1.35% of portfolio
-
Black Rock Inc. New York, NY4MShares$42.6 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.51MShares$37.4 Million0.08% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$36.7 Million0.52% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $431M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...